FangyuLei/tatqa huggingface dataset:
As of December 31,
As of December 31,
As of December 31,
As of December 31,
As of December 31,
2019
2018
2017
2016
2015
(In thousands)
(In thousands)
(In thousands)
(In thousands)
(In thousands)
Cash and cash equivalents
$19,505
$18,017
$22,553
$26,838
$35,128
Working capital
$1,116
$6,356
$7,646
$14,643
$16,046
Total assets
$54,538
$43,424
$45,672
$53,530
$68,579
Stockholders' equity
$10,863
$14,059
$13,078
$18,064
$21,387
item 6 .
selected consolidated financial data .
the following table presents selected consolidated financial data as of and for the five-year period ended december 31 2019 .
our past results of operations are not necessarily indicative of our future results of operations .
the following selected consolidated financial data is qualified in its entirety by and should be read in conjunction with “ management ' s discussion and analysis of financial condition and results of operations ” and the consolidated financial statements and the notes thereto included elsewhere herein .
consolidated balance sheet data : .

Question: What is the percentage change for cash and cash equivalents between 2018 and 2019?
Answer: 8.26
Services
2018 ($)
2019 ($)
Audit Fees
5,859,755
5,024,093
Audit-Related Fees
137,420
3,178,737
Tax Fees
1,440,168
2,346,879
All Other Fees
11,200
10,955
Total
7,448,544
10,560,664
ernst & young llp .
ernst & young llp fees incurred by us for fiscal 2018 and 2019 were as follows : .
audit fees : audit fees for fiscal 2018 and 2019 were for professional services rendered in connection with audits of our consolidated financial statements statutory audits of our subsidiary companies quarterly reviews and assistance with documents that we filed with the sec -including our forms 10-q and 8-k for periods covering fiscal 2018 and 2019 .
audit-related fees : audit-related fees for 2018 and 2019 were for professional services rendered in connection with consultations with management on various accounting matters including audit of financial statements of a carve-out entity and sell-side due diligence with respect to our previously announced spin-off .
tax fees : tax fees for 2018 and 2019 were for tax compliance and consulting services .
all other fees : other fees in 2018 and 2019 were for access to technical accounting services .

Question: What are the components of the fees incurred?
Answer: Audit Fees Audit-Related Fees Tax Fees All Other Fees
Fiscal Year
Fiscal Year
Fiscal Year
Variance in
2019
2019
2018
Dollars
Percent
(In millions, except for percentages)
Sales and marketing
$1,493
$1,593
$(100)
(6)%
Research and development
913
956
(43)
(4)%
General and administrative
447
574
(127)
(22)%
Amortization of intangible assets
207
220
(13)
(6)%
Restructuring, transition and other costs
241
410
(169)
(41)%
Total
$3,301
$3,753
$(452)
(12)%
operating expenses .
sales and marketing expense decreased primarily due to a $ 51 million decrease in stock-based compensation expense and a $ 41 million decrease as a result of the divestiture of our wss and pki solutions .
research and development expense decreased primarily due to a $ 66 million decrease in stockbased compensation expense .
general and administrative expense decreased primarily due to a $ 130 million decrease in stock-based compensation expense .
amortization of intangible assets decreased primarily due to the intangible assets sold with the divestiture of wss and pki solutions .
restructuring transition and other costs reflect a decrease of $ 70 million in fiscal 2019 compared to fiscal 2018 in severance and other restructuring costs .
in addition fiscal 2018 costs included $ 88 million of transition related costs related to our fiscal 2018 divestiture of our wss and pki solutions compared to $ 3 million in fiscal 2019 .

Question: What is the decrease in  Research and development  from Fiscal year 2018 to 2019?
Answer: 43
December 31,
December 31,
2019
2018
Balance at the beginning of the period
$3,282
$3,642
Service cost
405
448
Interest cost
254
196
Actuarial (gains) losses
(108)
(783)
Benefits paid
(22)
(32)
Effect of foreign currency translation
122
(189)
Balance at the end of the period
$3,933
$3,282
Unfunded status
(3,933)
(3,282)
Net amount recognized
$(3,933)
$(3,282)
note 23 .
defined benefit pension plan and postretirement benefits .
defined benefit pension plans .
the company sponsors non-contributory defined benefit pension plans -the “ pension plans ” for its covered employees in the philippines .
the pension plans provide defined benefits based on years of service and final salary .
all permanent employees meeting the minimum service requirement are eligible to participate in the pension plans .
as of december 31 2019 the pension plans were unfunded .
the company expects to make no cash contributions to its pension plans during 2020 .
the following table provides a reconciliation of the change in the benefit obligation for the pension plans and the net amount recognized included in “ other long-term liabilities ” in the accompanying consolidated balance sheets -in thousands : .

Question: What was the service cost in 2019?
Answer: 405
Authorized Shares
Issued and Out- standing Shares
Common Stock
Balance as of January 1, 2017  
180,000,000
101,969,666
1,020
Common Shares Issued in Follow-on Offering
-
40,000,000
400
Balance as of December 31, 2017  
180,000,000
141,969,666
1,420
Authorization of additional authorized shares  
180,000,000
-
-
Balance as of December 31, 2018  
360,000,000
141,969,666
1,420
At-the-Market Offering  
-
5,260,968
52
Balance as of December 31, 2019  
360,000,000
147,230,634
1,472
14 .
shareholders ’ equity .
authorized issued and outstanding common shares roll-forward is as follows : .
in december 2017 the company completed an underwritten public offering of 40000000 common shares which increased its equity by $ 103 .
7 million .
in december 2018 the annual general meeting of the company approved to increase the company ’ s authorized share capital from $ 1 .
8 million to $ 3 .
6 million .
during 2019 the company has issued 5260968 shares through the atm program and raised net proceeds of $ 17 .
9 million .

Question: In December 2017, what was the increase in equity from the Company's underwritten public offering?
Answer: $103.7 million
Number of Shares
Weighted-Average Grant-Date
(in thousands)
Fair Value per Share
Outstanding at December 31, 2018
3,263
$20.23
Granted
1,580
23.23
Vested
(1,541)
20.16
Canceled
(378)
21.52
Outstanding at December 31, 2019
2,924
21.72
restricted stock units .
a summary of the company ’ s restricted stock unit activity is as follows : .
performance-based restricted stock units .
performance-based restricted stock units are eligible to vest at the end of each fiscal year in a three-year performance period based on the company ’ s annual growth rate in net sales and non-gaap diluted earnings per share -subject to certain adjustments over a multiple of four times the related results for the fourth quarter of 2018 relative to the growth rates for a peer group of companies for the same metrics and periods .
for the performance-based restricted stock units granted in 2019 60 % of each performance-based award is subject to the net sales metric for the performance period and 40 % is subject to the non-gaap diluted earnings per share metric for the performance period .
the maximum percentage for a particular metric is2 50 % of the target number of units subject to the award related to that metric however vesting of the performance stock units is capped at 30 % and 100 % respectively of the target number of units subject to the award in years one and two respectively of the three-year performance period .
as of december 31 2019 the company believes that it is probable that the company will achieve performance metrics specified in the award agreement based on its expected revenue and non-gaap diluted eps results over the performance period and calculated growth rates relative to its peers ’ expected results based on data available as defined in the award agreement .

Question: What was the number of shares granted in 2019?
Answer: 1,580
Period
Total number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
October 1 - October 31, 2019
13,425
$78.21
13,425
$48,950,059
November 1 - November 30, 2019
245,454
76.95
245,454
30,062,919
December 1 - December 31, 2019
185,973
80.95
185,973
15,008,242
Total
444,852
444,852
in the following table we provide information regarding our common stock repurchases under our publicly-announced share repurchase program for the quarter ended december 31 2019 .
all repurchases related to the share repurchase program were made on the open market .
during the year ended december 31 2019 we repurchased a total of 1640055 shares at an average price per share of $ 70 .
65 under our publicly-announced share repurchase program .
in january 2020 our board of directors authorized the company to repurchase up to an aggregate of $ 50 million of the company ’ s common stock .

Question: How many shares are repurchased in 2019 October?
Answer: 13,425
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
2019
2018
2017
Stock options
223,259
229,294
258,917
Restricted stock awards
—
—
129
Restricted stock units
136,600
148,175
188,050
Common stock subject to repurchase
250
957
13,281
the following securities have been excluded from the calculation of diluted weighted average common shares outstanding as the inclusion of these securities would have an anti-dilutive effect : .
participating securities are composed of certain stock options granted under the 2015 plan and previously granted under the 2009 equity incentive plan that may be exercised before the options have vested .
unvested shares have a non-forfeitable right to dividends .
unvested shares issued as a result of early exercise are subject to repurchase by us upon termination of employment or services at the original exercise price .
the common stock subject to repurchase is no longer classified as participating securities when shares revert to common stock outstanding as the awards vest and our repurchase right lapses .
our redeemable noncontrolling interest relates to our 85 % equity ownership interest in openeye .
the openeye stockholder agreement contains a put option that gives the minority openeye stockholders the right to sell their openeye shares to us based on the fair value of the shares .
the openeye stockholder agreement also contains a call option that gives us the right to purchase the remaining openeye shares from the minority openeye stockholders based on the fair value of the shares .
the put and call options can each be exercised beginning in the first quarter of 2023 .
this redeemable noncontrolling interest is considered temporary equity and we report it between liabilities and stockholders ’ equity in the consolidated balance sheets .
the amount of the net income or loss attributable to redeemable noncontrolling interests is recorded in the consolidated statements of operations .

Question: How much were the Restricted stock units in 2019?
Answer: 136,600
December 31, 2019
December 31, 2018
Accounting
$36,161
$52,365
Research and development
650,584
137,114
Legal
15,273
32,161
Other
163,029
10,048
Total
$865,047
$231,688
note 4 - accounts payable and accrued expenses .
accounts payable and accrued expenses consist of the following at : .
on october 1 2019 the company entered into an agreement with a consultant for toxicology studies .
the consultant quoted a commitment of approximately $ 988000 as an estimate for the study .
50 % of the total price is to be paid upon the signing of the agreement 35 % of the total price is to be upon completion of the in-life study and the remaining 15 % of the total price is to be paid upon the issuance of the report .
if the company cancels the study the company will be required to pay a cancelation fee .
if the cancelation happens prior to the arrival of the test animals then the company will need to pay between 20 % and 50 % of the animal fees depending on when the cancellation happens .
if the cancellation occurs after the animals arrive but before the study begins then the company will be responsible for paying 50 % of the protocol price plus a fee of $ 7000 per room / week for animal husbandry until the animals can be relocated or disposed of .
if the company cancels the study after it has begun then the company will need to pay any fees for procured items for the study and any nonrecoverable expenses incurred by the vendor .
as of december 31 2019 the company has paid $ 0 and there is a balance of $ 493905 due .

Question: What is the percentage change in the accounts payable and accrued expenses between 2018 and 2019?
Answer: 273.37
(in thousands, except per share amounts)
Total Number of Shares Purchased (1) (2)
Average Price Paid per Share (1) (2)
Total Number of Shares Purchased as Part of Publicly Announced Share Repurchase Program (2)
Approximate Dollar Value of Shares That May Yet Be Purchased at Period End Under Publicly Announced Share Repurchased Programs (2)
October 1, 2019 - October 31, 2019
24
$71.89
12
$45,484
November 1, 2019 - November 30, 2019
108
$75.63
-
$45,484
December 1, 2019 - December 31, 2019
144
$76.64
-
$45,484
Total
276
$75.83
issuer purchases of equity securities .
common stock repurchased in the three months ended december 31 2019 : .
-1 shares withheld to cover the option exercise price and tax withholding obligations under the net settlement provisions of our stock compensation awards have been included in these amounts .
-2 see " stock repurchase program " in item 7 of this annual report for additional information .

Question: What is the difference in the number of shares bought between October and November?
Answer: 84
Year ended March 31,
Year ended March 31,
Year ended March 31,
Year ended March 31,
Year ended March 31,
2019 (1)
2018
2017 (1)
2016
2015
Consolidated Statements of Income data:
Net sales
$5,349.5
$3,980.8
$3,407.8
$2,173.3
$2,147.0
Special charges and other, net (2)
$33.7
$17.5
$98.6
$4.0
$2.8
Loss on settlement of debt (3)
$(12.6)
$(16.0)
$(43.9)
$—
$(50.6)
Net income from continuing operations
$355.9
$255.4
$170.6
$323.9
$365.3
Basic net income per common share from continuing operations
$1.51
$1.10
$0.79
$1.59
$1.84
Diluted net income per common share from continuing operations
$1.42
$1.03
$0.73
$1.49
$1.65
Dividends declared per common share
$1.457
$1.449
$1.441
$1.433
$1.425
Consolidated Balance Sheets data:
Total assets
$18,350.0
$8,257.2
$7,686.9
$5,537.9
$4,780.7
Net long-term debt and capital lease obligations, less current maturities (3)
$8,956.0
$1,769.1
$2,912.1
$2,465.8
$1,840.0
Microchip Technology stockholders' equity
$ 5,287.5
$ 3,279.8
$3,270.7
$ 2,150.9
$ 2,044.7
item 6 .
selected financial data .
you should read the following selected consolidated financial data for the five-year period ended march 31 2019 in conjunction with our consolidated financial statements and notes thereto and " management ' s discussion and analysis of financial condition and results of operations " included in items 7 and 8 of this form 10-k .
our consolidated statements of income data for each of the years in the three-year period ended march 31 2019 and the balance sheet data as of march 31 2019 and 2018 are derived from our audited consolidated financial statements included in item 8 of this form 10-k .
the statement of income data for the years ended march 31 2016 and 2015 and balance sheet data as of march 31 2017 2016 and 2015 have been derived from our audited consolidated financial statements not included herein -in the tables below all amounts are in millions except per share data .
-1 refer to note 2 to our consolidated financial statements for an explanation of our material business combinations during fiscal 2019 and fiscal 2017 .
-2 refer to note 4 to our consolidated financial statements for a discussion of the special charges and other net .
-3 refer to note 12 debt and credit facility for further discussion .

Question: What was the change in net sales between 2016 and 2017?
Answer: 1234.5
For the year ended December 31,
For the year ended December 31,
For the year ended December 31,
For the year ended December 31,
(in thousands, except percentages and per share data)
2019
2018
2017
Non-GAAP gross profit
$168,242
$163,376
$153,849
Non-GAAP gross margin
82.0%
84.6%
85.6%
Non-GAAP operating loss
$(8,689)
$(4,325)
$(16,440)
Non-GAAP operating margin
(4.2)%
(2.2)%
(9.1)%
Non-GAAP net loss
$(9,460)
$(4,548)
$(16,594)
Non-GAAP net loss per share
$(0.09)
$(0.04)
$(0.18)
Free cash flow
$(3,924)
$12,201
$(3,418)
free cash flow .
our non-gaap financial measures also include free cash flow which we define as cash provided by -used in operating activities less the amount of property and equipment purchased .
management believes that information regarding free cash flow provides investors with an important perspective on the cash available to invest in our business and fund ongoing operations .
however our calculation of free cash flow may not be comparable to similar measures used by other companies .
we believe these non-gaap financial measures are helpful in understanding our past financial performance and our future results .
our non-gaap financial measures are not meant to be considered in isolation or as a substitute for comparable gaap measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with gaap .
our management regularly uses our supplemental non-gaap financial measures internally to understand manage and evaluate our business and make operating decisions .
these non-gaap measures are among the primary factors management uses in planning for and forecasting future periods .
compensation of our executives is based in part on the performance of our business based on certain of these non-gaap measures .
we monitor the following non-gaap financial measures : .

Question: What is free cash flow?
Answer: cash provided by (used in) operating activities less the amount of property and equipment purchased
Year Ended December 31
Year Ended December 31
Year Ended December 31
Year Ended December 31
Year Ended December 31
2019
% Change
2018
% Change
2017
(In thousands, except percentage data)
(In thousands, except percentage data)
(In thousands, except percentage data)
(In thousands, except percentage data)
(In thousands, except percentage data)
Cost of revenue
$704,535
(1.8)%
$717,118
(2.0)%
$731,453
Gross margin percentage
29.5%
32.3%
29.6%
2019 vs 2018 .
cost of revenue decreased for the year ended december 31 2019 compared to the prior year primarily due to net revenue declining .
gross margin decreased for the year ended december 31 2019 compared to the prior year .
gross margin was negatively impacted by the imposition of section 301 tariffs originally announced in late 2018 and cost inefficiencies experienced in our new manufacturing locations outside of china an increase in channel promotional activities relative to revenue as well as foreign exchange headwinds due to the strengthening of the u .
s .
dollar .
2018 vs 2017 .
cost of revenue decreased for the year ended december 31 2018 primarily due to improved product margin performance lower proportionate provisions for warranty expense and lower air freight costs compared to the prior year .
gross margin increased for the year ended december 31 2018 compared to the prior year primarily due to improved product margin performance lower proportionate provisions for sales returns and warranty expense favorable foreign exchange rate movements and lower air freight costs compared to the prior year .
for fiscal 2020 we expect gross margins to improve from fiscal 2019 primarily as our u .
s .
bound inventory will primarily not be subject to section 301 tariffs in fiscal 2020 .
forecasting gross margin percentages is difficult and there are a number of risks related to our ability to maintain or improve our current gross margin levels .
our cost of revenue as a percentage of net revenue can vary significantly based upon factors such as : uncertainties surrounding revenue levels including future pricing and / or potential discounts as a result of the economy or in response to the strengthening of the u .
s .
dollar in our international markets and related production level variances ; import customs duties and imposed tariffs ; competition ; changes in technology ; changes in product mix ; variability of stockbased compensation costs ; royalties to third parties ; fluctuations in freight and repair costs ; manufacturing and purchase price variances ; changes in prices on commodity components ; warranty costs ; and the timing of sales particularly to service provider customers .
we expect that revenue derived from paid subscription service plans will increase in the future which may have a positive impact on our gross margin .
from time to time however we may experience fluctuations in our gross margin as a result of the factors discussed above .

Question: Which year has the highest gross margin percentage?
Answer: 2018
December 31,
December 31,
2018
2019
Balance January 1
6,562
7,955
Charged to cost of sales
18,408
26,301
Deductions
(8,985)
(12,232)
Releases of expired warranty
(8,214)
(5,684)
Foreign currency translation effect
184
84
Balance December 31
7,955
16,424
note 14 .
provision for warranty .
the changes in the amount of provision for warranty are as follows : .
costs of warranty include the cost of labor and materials to repair a product during the warranty period .
the main term of the warranty period is one year .
the company accrues for the estimated cost of the warranty on its products shipped in the provision for warranty upon recognition of the sale of the product .
the costs are estimated based on actual historical expenses incurred and on estimated future expenses related to current sales and are updated periodically .
actual warranty costs are charged against the provision for warranty .

Question: Which year had a larger difference in the balance between the start and the end of the year?
Answer: 2019